SCHEMBL24348256

SCHEMBL24348256

COc1nc(F)c(-c2ccccc2)c2sc(NC(=O)/C(=C/N)N=O)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.34
ADORA1 P30542 3/20 0.34
ALOX5 P09917 1/20 0.34
KMT2A Q03164 4/20 0.33
MAPT P10636 4/20 0.33
MEN1 O00255 3/20 0.33
NPSR1 Q6W5P4 3/20 0.33
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 3/20 0.33
ADORA3 P0DMS8 2/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
CHRM4 P08173 2/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
USP2 O75604 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20705359 0.75 ALDH1A1 (0.37) NPC1KMT2AMAPTMEN1ALDH1A1
SCHEMBL29605460 0.74 ADORA1 (0.38) NPC1ADORA1KMT2AMAPTMEN1
SCHEMBL20705360 0.72 CYP3A4 (0.38) NPC1ADORA1MAPTALDH1A1RAB9A
SCHEMBL30128119 0.69 ADORA2A (0.44) NPC1ADORA1ALDH1A1RAB9AADORA3
SCHEMBL24349638 0.69 MAPT (0.38) NPC1ADORA1KMT2AMAPTMEN1
SCHEMBL24349637 0.69 ADORA2B (0.37) NPC1ADORA1KMT2AMAPTMEN1
SCHEMBL24348878 0.66 CYP1A2 (0.41) ADORA1ALDH1A1ADORA3ADORA2AADORA2B
SCHEMBL29605871 0.66 CYP1A2 (0.41) ADORA1ALDH1A1ADORA3ADORA2AADORA2B
SCHEMBL24348798 0.65 ALDH1A1 (0.46) NPC1ADORA1KMT2AMAPTMEN1
SCHEMBL29605867 0.65 ADORA2A (0.51) ADORA1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119412-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119412-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS ADORA1, ADORA2A, ADORA3 NPC1 944/4885ADORA1 1/4885ALOX5 1951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.